腹膜透析市场规模、份额和成长分析（按产品、方式、适用疾病、最终用户、地区）：产业预测（2024-2031）

2022年全球腹膜透析市场规模为84.7亿美元，从2023年的89.4亿美元增长到2031年的138.3亿美元，在预测期内（2024-2031年）预计复合年增长率为5.6%。

腹膜透析（PD）市场由于其相对于传统血液透析机的优势而正在经历显着增长，特别是对于残余肾功能的患者。 PD 对患者来说是一种有吸引力的治疗方法，因为它允许灵活的家庭治疗、最大限度地减少医院就诊和严格的饮食限制。目前家庭透析治疗尤其是PD使用的增加体现在2023年至2019年，2年以内的终末期肾病（ESKD）患者的使用率将从14.8%增加到20%。然而，由于对週期计仪设备的恐惧症，尤其是老年患者，商业性挑战仍然存在。 COVID-19 后，不断增长的医疗需求、对创新解决方案的需求以及政府的支持措施预计将推动全球腹膜透析市场的发展，进一步凸显其在肾臟护理中日益增长的相关性。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术分析
• 贸易分析
• 监管分析
• 专利分析
• 案例研究分析

全球腹膜透析市场规模及复合年增长率：按产品划分（2024-2031）

• 市场概况
• 腹膜透析产品
  • 腹膜透析液袋
  • 腹膜透析机
  • 腹膜透析导管
  • 腹膜透析转运装置
  • 其他腹膜透析产品
• 腹膜透析服务

全球腹膜透析市场规模及复合年增长率：依方式分类（2024-2031）

• 市场概况
• 连续性移动式腹膜透析（CAPD）
• 自动腹膜透析（APD）

全球腹膜透析市场规模及复合年增长率：依适用疾病分类（2024-2031）

• 市场概况
• 末期肾病
• 急性肾损伤
• 其他疾病

全球腹膜透析市场规模及复合年增长率：按最终用户划分（2024-2031）

• 市场概况
• 居家医疗
• 医院/独立透析中心
• 其他最终用户

全球腹膜透析市场规模/复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• 费森尤斯医疗保健股份公司（德国）
• 百特国际公司（美国）
• 美敦力公司（爱尔兰）
• 达维塔公司（美国）
• 贝克顿迪金森公司（美国）
• 泰尔茂株式会社（日本）
• 犹他医疗产品公司（美国）
• Diaverum AB（瑞典）
• 医学（美国）
• 纽索尔科技公司（美国）
• 阿波罗透析私人有限公司（印度）
• 美国肾臟护理公司（美国）
• 西北肾臟中心（美国）
• 雷拉沃（美国）
• 米特拉工业私人有限公司（印度）
• JMS有限公司（日本）
• 阿美卡特（中国）
• 综合医学（印度）
• 华仁药业（中国）
• 阿瓦克科技（新加坡）

结论和建议

Global Peritoneal Dialysis Market size was valued at USD 8.47 billion in 2022 and is poised to grow from USD 8.94 billion in 2023 to USD 13.83 billion by 2031, growing at a CAGR of 5.6% during the forecast period (2024-2031).

The peritoneal dialysis (PD) market is experiencing significant growth, driven by its advantages over traditional hemodialysis, particularly for patients with remaining renal function. PD allows for flexible, home-based treatment, minimizing hospital visits and tough dietary restrictions, making it appealing to patients. Today's increasing use of home dialysis, particularly PD, is evident as its utilization rose from 14.8% to 20% among patients with less than two years of end-stage kidney disease (ESKD) between 2023 and 2019. However, commercial challenges persist, especially among older patients, due to technophobia regarding cycler equipment. Post-COVID-19, rising healthcare demands, demand for innovative solutions, and supportive government initiatives are expected to propel the global PD market, further highlighting its growing relevance in renal care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peritoneal Dialysis Market Segmental Analysis

Global Peritoneal Dialysis Market is segmented by offering, modality, disease indication, end user and region. Based on offering, the market is segmented into peritoneal dialysis products and peritoneal dialysis services. Based on modality, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on disease indication, the market is segmented into end-stage renal disease, acute kidney injury and other diseases. Based on end user, the market is segmented into home care settings, hospitals & independent dialysis centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is driven by several key factors, including the rising prevalence of end-stage renal disease (ESRD), advancements in the technology of peritoneal dialysis cyclers, and an increasing demand for home dialysis treatment options. Peritoneal dialysis offers numerous advantages such as lower costs compared to hemodialysis, a needle-free approach, enhanced mobility, ease of use, and fewer dietary restrictions, all of which contribute to its global market growth. Furthermore, the escalating need for home care dialysis services reflects the growing trend of treating both acute and chronic kidney disease patients in outpatient or home settings. With over 800 million individuals affected by chronic kidney disease worldwide, the demand for effective renal home treatments continues to rise, particularly in low- and middle-income countries where the burden is disproportionately significant.

Restraints in the Global Peritoneal Dialysis Market

The global peritoneal dialysis market faces several significant restraints that hinder its growth potential. Key challenges include a heightened risk of infections and complications associated with treatment failure, which can deter patients and healthcare providers from opting for this method. Additionally, the necessity for permanent catheter insertion outside the body raises concerns about long-term health risks and patient comfort. Furthermore, the complex and often lengthy approval processes for new dialysis devices can stifle innovation and limit the availability of improved treatment options. Together, these factors contribute to a cautious approach towards the adoption of peritoneal dialysis solutions in the healthcare sector.

Market Trends of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is witnessing significant growth, spurred by the rising prevalence of End Stage Renal Disease (ESRD) and associated conditions such as diabetes and hypertension. Increased public awareness and government initiatives aimed at expanding access to dialysis options are further enhancing market dynamics. The demand for advanced treatment technologies is also on the rise, reflecting a shift towards more efficient and patient-friendly solutions. Additionally, the growing adoption of peritoneal dialysis in developing regions like China and India presents new opportunities, positioning the market for sustained expansion in the coming years, driven by evolving healthcare needs globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Trade Analysis
• Regulatory Analysis
• Patent Analysis
• Case Study Analysis

Global Peritoneal Dialysis Market Size by Offering & CAGR (2024-2031)

• Market Overview
• Peritoneal Dialysis Products
  • Peritoneal Dialysis Solution Bags
  • Peritoneal Dialysis Machines
  • Peritoneal Dialysis Catheters
  • Peritoneal Dialysis Transfer Sets
  • Other Peritoneal Dialysis Products
• Peritoneal Dialysis Services

Global Peritoneal Dialysis Market Size by Modality & CAGR (2024-2031)

• Market Overview
• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

Global Peritoneal Dialysis Market Size by Disease Indication & CAGR (2024-2031)

• Market Overview
• End-Stage Renal Disease
• Acute Kidney Injury
• Other Diseases

Global Peritoneal Dialysis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Home Care Settings
• Hospitals & Independent Dialysis Centers
• Other End Users

Global Peritoneal Dialysis Market Size & CAGR (2024-2031)

• North America (Offering, Modality, Disease Indication, End User)
  • USA
  • Canada
• Europe (Offering, Modality, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Modality, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Modality, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Modality, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Fresenius Medical Care AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Utah Medical Products, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medionics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newsol Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Dialysis Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• U.S. Renal Care, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Northwest Kidney Centers (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Relavo (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitra Industries Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huaren Pharmaceutical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Awak Technologies (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations